메뉴 건너뛰기




Volumn 13, Issue 3, 2001, Pages 240-246

Neuropsychiatric assessment of Alzheimer's disease and related dementias

Author keywords

Agitation; Alzheimer's disease; Behavioral alterations; Neuropsychiatric assessment; Neuropsychiatric Inventory (NPI); Neuropsychological impairment; Psychosis

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; METRIFONATE; OLANZAPINE; PLACEBO; PSYCHOTROPIC AGENT; RIVASTIGMINE;

EID: 0034962264     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03351482     Document Type: Review
Times cited : (79)

References (48)
  • 1
    • 0004278345 scopus 로고
    • Dementia: A Clinical Approach
    • Butterworth-Heinemann, Boston
    • (1992)
    • Benson, D.F.1
  • 4
    • 85021274528 scopus 로고
    • American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. American Psychiatric Association, Washington, DC
    • (1994)
  • 6
    • 0028223015 scopus 로고
    • Consensus statement: Clinical and neuropathological criteria for frontotemporal dementia
    • Lund and Manchester Groups
    • (1994) J. Neurol. Neurosurg. Psychiatry , vol.57 , pp. 416-418
  • 13
    • 0030958347 scopus 로고    scopus 로고
    • The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients
    • (1997) Neurology , vol.48 , pp. S10-S16
    • Cummings, J.L.1
  • 34
    • 0003652390 scopus 로고    scopus 로고
    • Behavioral benefits in Alzheimer's disease patients residing in a nursing home following 52 weeks of rivastigmine treatment
    • American Psychiatric Association, 153rd Meeting
    • (2000)
    • Cummings, J.L.1    Anand, R.2    Koumaras, B.3    Hartman, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.